These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 24692707)

  • 21. Manumycin A induces apoptosis in malignant pleural mesothelioma through regulation of Sp1 and activation of the mitochondria-related apoptotic pathway.
    Kim KH; Chae JI; Oh H; Cho JH; Lee RH; Yoon G; Cho SS; Cho YS; Lee MH; Liu K; Lee HJ; Shim JH
    Oncol Rep; 2016 Jul; 36(1):117-24. PubMed ID: 27176604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trametinib plus 4-Methylumbelliferone Exhibits Antitumor Effects by ERK Blockade and CD44 Downregulation and Affects PD-1 and PD-L1 in Malignant Pleural Mesothelioma.
    Cho H; Matsumoto S; Fujita Y; Kuroda A; Menju T; Sonobe M; Kondo N; Torii I; Nakano T; Lara PN; Gandara DR; Date H; Hasegawa S
    J Thorac Oncol; 2017 Mar; 12(3):477-490. PubMed ID: 27867002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progranulin and granulin-like protein as novel VEGF-independent angiogenic factors derived from human mesothelioma cells.
    Eguchi R; Nakano T; Wakabayashi I
    Oncogene; 2017 Feb; 36(5):714-722. PubMed ID: 27345409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma.
    Kanteti R; Riehm JJ; Dhanasingh I; Lennon FE; Mirzapoiazova T; Mambetsariev B; Kindler HL; Salgia R
    Sci Rep; 2016 Sep; 6():32992. PubMed ID: 27623107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metformin produces growth inhibitory effects in combination with nutlin-3a on malignant mesothelioma through a cross-talk between mTOR and p53 pathways.
    Shimazu K; Tada Y; Morinaga T; Shingyoji M; Sekine I; Shimada H; Hiroshima K; Namiki T; Tatsumi K; Tagawa M
    BMC Cancer; 2017 May; 17(1):309. PubMed ID: 28464864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteopontin modulates malignant pleural mesothelioma cell functions in vitro.
    Ohashi R; Tajima K; Takahashi F; Cui R; Gu T; Shimizu K; Nishio K; Fukuoka K; Nakano T; Takahashi K
    Anticancer Res; 2009 Jun; 29(6):2205-14. PubMed ID: 19528482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trabectedin Is Active against Malignant Pleural Mesothelioma Cell and Xenograft Models and Synergizes with Chemotherapy and Bcl-2 Inhibition In Vitro.
    Hoda MA; Pirker C; Dong Y; Schelch K; Heffeter P; Kryeziu K; van Schoonhoven S; Klikovits T; Laszlo V; Rozsas A; Ozsvar J; Klepetko W; Döme B; Grusch M; Hegedüs B; Berger W
    Mol Cancer Ther; 2016 Oct; 15(10):2357-2369. PubMed ID: 27512118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In Vitro and In Vivo Antitumor Activity of [Pt(O,O'-acac)(γ-acac)(DMS)] in Malignant Pleural Mesothelioma.
    Muscella A; Vetrugno C; Cossa LG; Antonaci G; De Nuccio F; De Pascali SA; Fanizzi FP; Marsigliante S
    PLoS One; 2016; 11(11):e0165154. PubMed ID: 27806086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blockage of epithelial to mesenchymal transition and upregulation of let 7b are critically involved in ursolic acid induced apoptosis in malignant mesothelioma cell.
    Sohn EJ; Won G; Lee J; Yoon SW; Lee I; Kim HJ; Kim SH
    Int J Biol Sci; 2016; 12(11):1279-1288. PubMed ID: 28090191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Free fatty acids inhibit protein tyrosine phosphatase 1B and activate Akt.
    Shibata E; Kanno T; Tsuchiya A; Kuribayashi K; Tabata C; Nakano T; Nishizaki T
    Cell Physiol Biochem; 2013; 32(4):871-9. PubMed ID: 24107614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteomic differential display analysis identified upregulated astrocytic phosphoprotein PEA-15 in human malignant pleural mesothelioma cell lines.
    Kuramitsu Y; Miyamoto H; Tanaka T; Zhang X; Fujimoto M; Ueda K; Tanaka T; Hamano K; Nakamura K
    Proteomics; 2009 Nov; 9(22):5078-89. PubMed ID: 19771552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apoptosis by [Pt(O,O'-acac)(γ-acac)(DMS)] requires PKC-δ mediated p53 activation in malignant pleural mesothelioma.
    Muscella A; Vetrugno C; Cossa LG; Antonaci G; Barca A; De Pascali SA; Fanizzi FP; Marsigliante S
    PLoS One; 2017; 12(7):e0181114. PubMed ID: 28704484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EGFR-dependent signalling reduced and p38 dependent apoptosis required by Gallic acid in Malignant Mesothelioma cells.
    Demiroglu-Zergeroglu A; Candemir G; Turhanlar E; Sagir F; Ayvali N
    Biomed Pharmacother; 2016 Dec; 84():2000-2007. PubMed ID: 27847212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic targeting of malignant pleural mesothelioma cells by MDM2 inhibitors and TRAIL agonists.
    Urso L; Cavallari I; Silic-Benussi M; Biasini L; Zago G; Calabrese F; Conte PF; Ciminale V; Pasello G
    Oncotarget; 2017 Jul; 8(27):44232-44241. PubMed ID: 28562336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of protein kinase C α/βII and activation of c-Jun NH2-terminal kinase mediate glycyrrhetinic acid induced apoptosis in non-small cell lung cancer NCI-H460 cells.
    Song J; Ko HS; Sohn EJ; Kim B; Kim JH; Kim HJ; Kim C; Kim JE; Kim SH
    Bioorg Med Chem Lett; 2014 Feb; 24(4):1188-91. PubMed ID: 24461294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Curcumin induces apoptosis and inhibits angiogenesis in murine malignant mesothelioma.
    Zhang C; Hao Y; Wu L; Dong X; Jiang N; Cong B; Liu J; Zhang W; Tang D; De Perrot M; Zhao X
    Int J Oncol; 2018 Dec; 53(6):2531-2541. PubMed ID: 30272283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional analysis of c-Met/hepatocyte growth factor pathway in malignant pleural mesothelioma.
    Jagadeeswaran R; Ma PC; Seiwert TY; Jagadeeswaran S; Zumba O; Nallasura V; Ahmed S; Filiberti R; Paganuzzi M; Puntoni R; Kratzke RA; Gordon GJ; Sugarbaker DJ; Bueno R; Janamanchi V; Bindokas VP; Kindler HL; Salgia R
    Cancer Res; 2006 Jan; 66(1):352-61. PubMed ID: 16397249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic anti-tumor effect of bullfrog sialic acid-binding lectin and pemetrexed in malignant mesothelioma.
    Satoh T; Tatsuta T; Sugawara S; Hara A; Hosono M
    Oncotarget; 2017 Jun; 8(26):42466-42477. PubMed ID: 28476017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypoxia Inducible Factor-1α Inhibition in Von Hippel Lindau-mutant Malignant Pleural Mesothelioma Cells.
    Shukuya T; Oyanagi J; Serizawa M; Watanabe M; Yamamoto N; Koh Y
    Anticancer Res; 2020 Apr; 40(4):1867-1874. PubMed ID: 32234874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional Analysis of the Adrenomedullin Pathway in Malignant Pleural Mesothelioma.
    Greillier L; Tounsi A; Berenguer-Daizé C; Dussault N; Delfino C; Benyahia Z; Cayol M; Mabrouk K; Garcia S; Martin PM; Barlesi F; Ouafik L
    J Thorac Oncol; 2016 Jan; 11(1):94-107. PubMed ID: 26762744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.